Serrapeptamed
Natural health product licensed in Canada
- Other names
- Inflamed, Inflamed +, Rehab, Traumaforte, Traumamed
- Licence holder
- Les Importations Herbasanté Inc.
- NPN or DIN-HM
- 80130284
- Status
- Active licence
- Licence date
- 26 March 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Harpagophytum procumbens Source : Harpagophytum procumbens - Secondary root tuber Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 300 mg | 75 mg | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var. comosus - fruit | 20,400 FCC PU | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var. comosus - fruit | 100 mg | Not calculated |
| Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Partially hydrolysed chicken eggshell membrane | 166.6 mg | Not calculated |
| Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Gallus gallus - Coquille d'oeuf | 166.6 mg | Not calculated |
| Serrapeptase Source : Serratia marcescens E-15 - Cellule Entiière | 40,000 SPU | Not calculated |
| Serrapeptase Source : Serratia marcescens E-15 - Cellule Entiière | 20 mg | Not calculated |
Non-medicinal ingredients
Cellulose, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Contains serrapeptidase, a Proteolytic Enzyme. Helps reduce and/or relieve postoperative cheek swelling and/or pain after dental surgery. Contains bromelain, a Digestive enzyme. Helps to reduce joint pain and reduce stiffness. Clinically proven to help reduce joint pain in 7-10 days. Used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis. NEM® increases joint flexibility. NEM® helps reduce joint pain and stiffness. NEM® helps to relieve joint pain and stiffness associated with osteoarthritis (of the knee). NEM® is clinically proven to reduce joint pain in 7 to 10 days. NEM® helps to minimize discomfort due to moderate intensity aerobic exercise in post-menopausal women. NEM® helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. NEM® helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. NEM® helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women. NEM® helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day). NEM® starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days. NEM® is clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days). NEM® helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise. NEM® helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise. NEM® helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80130284
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.